Stocks/ARM

ARM three-lens brief

Evidence-based stock research on ARM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

ARM · Nightly brief
Inspect

Outperforming SPY by 24.8pp over 30 days. · P/E of 246 — priced for high growth; little margin of safety.

  • Outperforming SPY by 24.8pp over 30 days.
  • P/E of 246 — priced for high growth; little margin of safety.
  • Debt-to-equity of 5.2 — balance-sheet-heavy.

ARM closed at $209.07 (+0.56%) as of 2026-05-13. Market cap: $222.46B. P/E (trailing) 246.0. Positives: outperforming SPY by 24.8pp over 30 days.. Concerns: p/E of 246 — priced for high growth; little margin of safety.; debt-to-equity of 5.2 — balance-sheet-heavy.. Last quarter: Revenue $1.49B, net income $313.00M, free cash flow $824.75M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on ARM, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ARMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ARM"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ARM brief"></iframe>